The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class… The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class…

NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction

2025/11/05 18:32


Zach Anderson
Nov 04, 2025 20:41

NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries.

NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress.

Transforming Structure Prediction

The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline.

Technological Advancements

The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally.

Practical Applications and Deployment

OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results.

Open Science and Enterprise Reliability

The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class 1 open-source system, it ensures transparency and reproducibility.

Federated Learning and Global Collaboration

OpenFold3 has proven its capability to scale across global R&D environments through secure federated workflows validated by Apheris and SandboxAQ. This allows partners to fine-tune models on proprietary data without sharing sensitive datasets, maintaining regulatory compliance while enhancing model performance with diverse datasets.

The Future of Protein AI

OpenFold3 represents more than just a technological advancement; it is a foundation for future developments in protein AI. By converging open-source science, accelerated computing, and federated collaboration, it ensures that the tools used by global researchers meet enterprise standards for reliability and security.

Image source: Shutterstock

Source: https://blockchain.news/news/nvidia-openfold3-nim-advancing-biomolecular-prediction

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

This Exclusive Cayman Getaway Tastes As Good As It Feels

This Exclusive Cayman Getaway Tastes As Good As It Feels

The post This Exclusive Cayman Getaway Tastes As Good As It Feels appeared on BitcoinEthereumNews.com. 1OAK’s Sand Soleil sits on Grand Cayman’s iconic Seven Mile Beach 1OAK Exhausted and professionally burnt out, I arrived at 1OAK’s Sand Soleil in search of the type of restoration that could still my mind and get me writing again. The seven-day culinary experience was a no-brainer for me as a food writer. The integration of an epicurean getaway with pure Cayman luxury seemed to be the perfect spark for my creativity—private chef dinners, deep dives into Caribbean flavors, and hands-on masterclasses, all located within a serene, oceanfront villa. I had finally arrived. With the last rays of the sun setting behind Grand Cayman’s famous Seven Mile Beach, casting a warm golden glow across the water, I tasted Chef Joe Hughes’ ceviche for the first time—cubes of wahoo cured in lime, with charred pineapple and a subtle, nutty crunch. Chef Joe Hughes’ love for bright, Asian-inspired flavours came through in this wahoo tataki layered with Vietnamese herbs, ripe papaya and mango, cashew and cilantro, all brought together with a nuoc cham. Jamie Fortune Something softened. For the first time in months, I began to feel present. Sophia List, the brainchild of the 1OAK experience, heard me well. With an intuition honed by years of curating luxury, she matched me with what she called “a vision realized.” List told me Sand Soleil—like the other 1OAK homes on Seven Mile Beach and in West Bay—was created to feel like a real sanctuary. For her, it’s the laid-back alternative to a busy hotel, a place where you get privacy and elegance without any fuss. “We wanted to introduce the Cayman Islands to something truly special—an ultra-luxury experience that combines exquisite design, maximum privacy, and a sense of calm,” she shared as she guided me through the four-bedroom villa. “We are so excited to…
Share
BitcoinEthereumNews2025/12/06 14:01
How Pros Buy Bitcoin Dips With DCA Like Institutions

How Pros Buy Bitcoin Dips With DCA Like Institutions

The post How Pros Buy Bitcoin Dips With DCA Like Institutions appeared on BitcoinEthereumNews.com. “Buy every dip.” That’s the advice from Strike CEO Jack Mallers. According to Mallers, with quantitative tightening over and rate cuts and stimulus on the horizon, the great print is coming. The US can’t afford falling asset prices, he argues, which translates into a giant wall of liquidity ready to muscle in and prop prices up. While retail has latched onto terms like “buy the dip” and “dollar-cost averaging” (DCA) for buying at market lows or making regular purchases, these are really concepts borrowed from the pros like Samar Sen, the senior vice president and head of APAC at Talos, an institutional digital asset trading platform. He says that institutional traders have used these terms for decades to manage their entry points into the market and build exposure gradually, while avoiding emotional decision-making in volatile markets. Source: Jack Mallers Related: Cryptocurrency investment: The ultimate indicators for crypto trading How institutions buy the dip Treasury companies like Strategy and BitMine have become poster children for institutions buying the dip and dollar-cost averaging (DCA) at scale, steadfastly vacuuming up coins every chance they get. Strategy stacked another 130 Bitcoin (BTC) on Monday, while the insatiable Tom Lee scooped up $150 million of Ether (ETH) on Thursday, prompting Arkham to post, “Tom Lee is DCAing ETH.” But while it may look like the smart money is glued to the screen reacting to every market downturn, the reality is quite different. Institutions don’t use the retail vocabulary, Samar explains, but the underlying ideas of disciplined accumulation, opportunistic rebalancing and staying insulated from short-term noise are very much present in how they engage with assets like Bitcoin. The core difference, he points out, is in how they execute those ideas. While retail investors are prone to react to headlines and price charts, institutional desks rely…
Share
BitcoinEthereumNews2025/12/06 13:53